About the conference: About the conference: STAR Conferences PHPN-2018 endeavors to provide the pediatrician and family physicians with the evidence-based medical knowledge to provide optimal care to the pediatrics.
oin the global experts in pediatric nurse practitioners, family nurse practitioners and their fellow pediatric providers for professional networking, continuing education in hot topics and social events.
PHPN 2018 conference agenda offers you cutting edge research educational sessions, intensive workshops, poster presentations and certification review courses.
Our keynote and general sessions will be presented by internationally-known experts in pediatric health and/or advanced practice nursing.
Benefits of attending:
The conference offers recognized plenary speakers to address the changing landscape of pediatric health care and advance quality of care for all children.
In-person and virtual meetings offer peer-to-peer and interdisciplinary networking simulation-based education, training and research in all subspecialties that care for infants and children.
Opportunity to earn Continuing Education/Continuing Medical Education credits for Counselors, Nurses, Physicians and Social Workers.
The global pediatric medicines market is expected to grow at a CAGR of close to 5% during the forecast period. Pediatric medicines market in Americas
The Americas accounts for more than 44% share of the global pediatric medicines market. The region is dominating the global market largely due to its established healthcare infrastructure and growing prevalence of respiratory and infectious diseases.
The growing rate of pediatric population is helping the market to sustain its growth. For instance, in 2016, the pediatric population in the US was 73.7 million, and it is expected to reach around 80 million by 2050.
Therefore, therapeutic advancement and highly focused research approach for pediatric drug development are required to cater to the needs of this huge population.
The evolving regulatory aspects are also impacting the research activity for ped meds development.
For instance, the National Institute of Health (NIH) has initiated Best Pharmaceuticals for Children Acts (BPCA) with the aim to improve the R&D of pediatric therapeutics.
Europe remains the second largest market for pediatric medicines with close to 34% of the market share. Within the region, Europe has a distinct advantage over rest of the region in terms of a well-defined pharmacy network, established healthcare infrastructure, well-orchestrated regulatory body, and sustained reimbursement scenario. These factors help Europe lead the market within the region.
The pediatric medicines market in Asia Pacific is one of the emerging markets in the world. China, Australia, Japan, and India are contributing a major share in the overall market in APAC. High pediatric population in this region is driving the market. Malnutrition, caused by poverty, are leading to various blood-related diseases, which will also fuel growth.